C07D 231/26
1-phenyl-3-methyl-5- pyrazolones, unsubstituted or substituted on the phenyl ring
Official title: 1-Phenyl-3-methyl-5- pyrazolones, unsubstituted or substituted on the phenyl ring
C07D231/26 (1-phenyl-3-methyl-5- pyrazolones, unsubstituted or substituted on the phenyl ring) appears on 63 US grants and 46 published applications in this corpus.
Search patents in C07D- Granted patents
- 63
- Published applications
- 46
- Assignees
- 51
- Inventors
- 221
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 4 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 2 |
| 2004 | 0 | 2 |
| 2005 | 1 | 3 |
| 2006 | 1 | 5 |
| 2007 | 0 | 5 |
| 2008 | 0 | 3 |
| 2009 | 2 | 0 |
| 2010 | 3 | 1 |
| 2011 | 3 | 0 |
| 2012 | 1 | 3 |
| 2013 | 0 | 0 |
| 2014 | 1 | 2 |
| 2015 | 1 | 1 |
| 2016 | 1 | 1 |
| 2017 | 3 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 2 |
| 2020 | 1 | 1 |
| 2021 | 1 | 2 |
| 2022 | 0 | 6 |
| 2023 | 2 | 3 |
| 2024 | 0 | 1 |
| 2025 | 5 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds for treating conditions related to oxidative stress4 Nov 2025US 12,459,900 B2
- ACSS2 inhibitors and methods of use thereof14 Oct 2025US 12,441,689 B2EpiVario, Inc.
- Analysis method of 3-methyl-1-phenyl-2-pyrazolin-5-one active pharmaceutical ingredient, treatment for amyotrophic lateral sclerosis, inhibition of progression of amyotrophic lateral sclerosis, and method of producing medicament containing 3-methyl-1-phenyl-2-pyrazolin-5-one active pharmaceutical ingredient3 Jun 2025US 12,320,793 B2Mitsubishi Tanabe Pharma Corporation
- 1,2-bis(diphenylphosphinoalkylamido)-1,2-disubstituted ethane, and its synthesis and application15 Apr 2025US 12,275,750 B2Zhejiang University
- Plastic container25 Feb 2025US 12,233,025 B2ZACROS Corporation
- Acss2 inhibitors and methods of use thereof26 Mar 2026US 2026/0085048 A1EpiVario, Inc.
- Compounds for treating conditions related to oxidative stress8 Aug 2024US 2024/0262794 A1
- Analysis method of 3-methyl-1-phenyl-2-pyrazolin-5-one active pharmaceutical ingredient, treatment for amyotrophic lateral sclerosis, inhibition of progression of amyotrophic lateral sclerosis, and method of producing medicament containing 3-methyl-1-phenyl-2-pyrazolin-5-one active pharmaceutical ingredient16 Nov 2023US 2023/0366867 A1Mitsubishi Tanabe Pharma Corporation
- Imidazole 3-oxide derivative based acss2 inhibitors and methods of use thereof8 Jun 2023US 2023/0174507 A1Metabomed Ltd.
- Acss2 inhibitors and methods of use thereof16 Mar 2023US 2023/0084752 A1Metabomed Ltd.
Most cited
By later US patents
- 1-(Substituted phenyl) aminoantipyrin compounds152US 4,394,512 ABoehringer Mannheim GmbH · 1983
- Neprilysin inhibitors61US 8,686,184 B2Theravance, Inc. · 2014
- Method and reagent for the determination of glycerin30US 4,399,218 ABoehringer Mannheim GmbH · 1983
- Herbicidal compositions based on substituted pyrazolin-5-one derivatives and use thereof26US 4,909,827 ABayer Aktiengesellschaft · 1990
- Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals26US 7,138,414 B2Sanofi-Aventis Deutschland GmbH · 2006